KALSI Clinical Education

Over the past 30 years the health professionals have witnessed an explosion of published research.  While our knowledge base has greatly improved, patient outcomes in difficult musculoskeletal problems such as back and shoulder pain, have not significantly benefitted from this increased evidence-base.

Many health practitioners and researchers now believe that a major failing of an "evidence-based" approach has been insufficient consideration of clinical complexity.  

In response to these issues our people have developed a series of randomised controlled trials aiming to show that high quality specific treatment works for musculoskeletal problems.

What do we mean by "high quality"?  Well, unlike most randomised controlled trials to date, our clinical research only investigates treatment that:
• Is developed by expert practitioners
• Incorporates the best evidence from all available sources
• Uses a classification approach where specific treatment is matched to different clinical subgroups
• Draws on commonly used methods (such as Maitland, McKenzie and Functional Restoration) rather than attempting to "reinvent the wheel"
• Addresses all components of the patient problem (eg pathoanatomical, psychosocial and neurophysiological)
• Incorporates emerging approaches such as advanced motor control, centrally mediated influences, and acceptanace and commitment therapy
• Is tailored to different patient presentations rather than "one size fits all"
• Provides structured guidance on clinical decision making but with sufficient flexibility for practitioners to vary the treatment components
• Can be reproduced by health practitioners across the world

The results of a number of our research programs have been finalised.  Excitingly our STOPS (Specific Treatment of Problems of the Spine) trial has shown for the first time that high quality specific treatment is effective compared to guideline based advice.  This study is important because advice has been vigorously promoted by evidence-based guidelines for the last decade.  The STOPS trials show that patients do much better and are far more satisfied if they have treatment specific to the nature of their injury rather than advice.

We will be continuing our follow up of patients in the STOPS trials for the next 24 months.  In parallel with this we are conducting similarly designed randomised controlled trials on shoulder and groin pain.

Through well designed research on high quality specific treatment we aim to improve the clinical outcomes for patients with musculoskeletal pain worldwide.

If you are interested, why not ask us a question on our Practitioner Advice Line.  Alternatively go to our Clinical Education page to see how KALSI can help.